
Joseph Geraci, CSO/CTO & Co-Founder at NetraMark
From Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere by Julio G. Martinez-Clark
May 15, 2026 · 51 min · Season 2 · Episode 129
About this episode
Dr. Joseph Geraci discusses the impact of artificial intelligence on medicine and clinical research.
In this episode, we sit down with Dr. Joseph Geraci — mathematical physicist, medical scientist, and AI innovator — to explore how artificial intelligence is transforming the future of medicine and clinical research. Dr. Geraci began his career in quantum computing and mathematical physics, earning his PhD under renowned scientist Dr. Daniel Lidar with research supported by DARPA and the U.S. Army’s Disruptive Technology Office. He later expanded his work into artificial intelligence for medi...
People in this episode
Host: Julio G. Martinez-Clark
Guest: Joseph Geraci
Topics covered
- artificial intelligence
- medicine
- clinical research
- quantum computing
- mathematical physics
Keywords
- artificial intelligence
- clinical research
- medicine
- quantum computing
- mathematical physics
Mentioned in this episode
Organizations: NetraMark, DARPA, U.S. Army’s Disruptive Technology Office
More episodes of Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
- Shareef Mahdavi, Founder at PX Movement · June 5, 2026 · 56 min
- Gary Zammit, President & CEO at Clinilabs Drug Development Corporation · April 17, 2026 · 46 min
- Joseph Grieco, VP at Tris Pharma & Liza Micioni, Sr. Director at Tris Pharma · April 10, 2026 · 53 min
- Robert Packard, President at Medical Device Academy, Inc · March 27, 2026 · 53 min
- Kristen Mittal, Co-founder and CEO of Mittal Consulting · March 20, 2026 · 37 min
- Tina Soulis, Founder and Director at Alithia Life Sciences · March 13, 2026 · 32 min
Explore listener stats, chart rankings, contacts and more on the Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere podcast page.